
BCYC vs DRUG
$BCYC vs $DRUG head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
BCYC vs DRUG: trend, levels and the market
One year to 2026-11-20, against the S&P 500 (+3.2%). Split-adjusted daily closes.
- ·Both are in downtrends, below their 50- and 200-day averages, so neither has turned up yet.
- ·Neither kept up with the market over the past year: BCYC -57% and DRUG -66.3%, against the S&P 500 at +3.2%.
Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.
BCYC vs DRUG: the quick read
- ·BCYC is the larger company by market cap ($203M vs $201M).
- ·DRUG has been more active on our scanner (111 vs 59 alerts in 30 days).
- ·DRUG has the smaller float (8.5M vs 55.9M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (PHARMACEUTICAL PREPARATIONS vs Pharmaceutical Preparations), so they answer to different catalysts and a move in one says little about the other.
- ·They trade in different worlds by share price: BCYC is a low-priced stock where a few cents is a real percentage move, while the other is priced for steadier increments.
- ·Both stay busy on our scanner, 111 and 59 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are closely matched in size, within 1% of each other on market cap, which makes the rest of this table the interesting part.
- ·Both sit in the bottom quarter of their 52-week range, so this is a comparison of two names well off their highs.
- ·BCYC is the one in play today, trading about 2.4x its normal volume, which is what puts a name on our scanner in the first place.
Objective differences only. Not investment advice.
Watching BCYC or DRUG? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing BCYC and DRUG on TheDesperateTrader.
- Is BCYC or DRUG the better stock?
- "Better" depends on your goal, and these two are not alike. BCYC is the larger company by market cap ($203M vs $201M). DRUG has been more active on our scanner (111 vs 59 alerts in 30 days). DRUG has the smaller float (8.5M vs 55.9M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between BCYC and DRUG?
- The differences that matter: they are not in the same business - BCYC is pharmaceutical preparations and DRUG is pharmaceutical preparations; they are similar in size ($203M vs $201M); they trade at very different share prices ($2.89 vs $20.40); BCYC sits at 1% of its 52-week range against 3% for DRUG; our scanner flagged BCYC 59 times in the last 30 days against 111 for DRUG. Everything above is measured from the latest completed session and SEC filings.
- Which of BCYC and DRUG is more active right now?
- Right now BCYC is at about 2.4x its normal volume and DRUG is at about 0.7x, so BCYC is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is BCYC or DRUG in the stronger trend?
- BCYC is below its 50-day average of $3.61 and below its 200-day average of $4.33; DRUG is below its 50-day average of $44.51 and below its 200-day average of $68.72. BCYC leads 4 of the 5 measures on this page (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading BCYC or DRUG? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysExplore the market
Free, live market tools. No account required to look.